Legend Capital returned as Xbiome secured an eight-digit dollar amount that wil support the progress of its microbiome drug pipeline.

The dental aligner provider closed a Ping An-backed series C round earlier this year but has now collected more funding in a Cadence Growth Capital-led round.

Haier Biomedical led a $15.2m round for the medical device maintenance service that also featured Zhejiang Orient Financial Holdings and Legend Capital.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The Codexis-backed SynBio Innovation Accelerator will target early-stage biotech developers and has made Arzeda its first portfolio company.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The $22.5m drug discovery fund is backed by University of Utah's Huntsman Cancer Institute and College of Pharmacy.

The proteomics technology provider, backed by Nan Fung, iCarbonX, Novartis, Otsuka and Quest Diagnostics, has now secured $485m in total.

The ophthalmic biotherapeutics developer has completed a series A round co-led by Eli Lilly unit Lilly Asia Ventures nine months after it was founded.